{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:13:29Z","timestamp":1793729609195,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"French Ministry of Health","award":["Protocole Hospitalier de Recherche Clinique PHRC national 2015"],"award-info":[{"award-number":["Protocole Hospitalier de Recherche Clinique PHRC national 2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1338-6","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:04:24Z","timestamp":1556625864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the efficacy of an interdialytic \u201cethanol 40% v\/v - enoxaparin 1000\u2009U\/mL\u201d lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-1264","authenticated-orcid":false,"given":"Julien","family":"Aniort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Piraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Adda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Perreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bouiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Guerraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Kalbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Krumel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne Leray","family":"Moragues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Thibaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Gustavo","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Vernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Weclawiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Elisabeth","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"issue":"6","key":"1338_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ki.2010.471","volume":"79","author":"CE Lok","year":"2011","unstructured":"Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in hemodialysis patients. Kidney Int. 2011;79(6):587\u201398.","journal-title":"Kidney Int"},{"issue":"3","key":"1338_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1681\/ASN.2012070643","volume":"24","author":"P Ravani","year":"2013","unstructured":"Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465\u201373.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1338_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/502580","volume":"26","author":"JJ Engemann","year":"2005","unstructured":"Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller LB, Schulman KA, Corey GR, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005;26(6):534\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"1338_CR4","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1128\/IAI.73.8.4596-4606.2005","volume":"73","author":"RM Shanks","year":"2005","unstructured":"Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun. 2005;73(8):4596\u2013606.","journal-title":"Infect Immun"},{"issue":"9","key":"1338_CR5","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1093\/ndt\/gfs081","volume":"27","author":"JJ Dixon","year":"2012","unstructured":"Dixon JJ, Steele M, Makanjuola AD. Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol Dial Transplant. 2012;27(9):3575\u201381.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1338_CR6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2215\/CJN.01270210","volume":"5","author":"DL Landry","year":"2010","unstructured":"Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 2010;5(10):1799\u2013804.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1338_CR7","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1681\/ASN.2004100870","volume":"16","author":"MC Weijmer","year":"2005","unstructured":"Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol. 2005;16(9):2769\u201377.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1338_CR8","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1093\/ndt\/gfn299","volume":"23","author":"G Winnett","year":"2008","unstructured":"Winnett G, Nolan J, Miller M, Ashman N. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant. 2008;23(11):3592\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1338_CR9","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/ndt\/gfg481","volume":"18","author":"HD Polaschegg","year":"2003","unstructured":"Polaschegg HD, Sodemann K. Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant. 2003;18(12):2688\u201390.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1338_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.01.259","volume":"53","author":"A Power","year":"2009","unstructured":"Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis. 2009;53(6):1034\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1338_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2215\/CJN.01760407","volume":"3","author":"JM Macrae","year":"2008","unstructured":"Macrae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol. 2008;3(2):369\u201374.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1338_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1053\/j.ajkd.2013.08.016","volume":"63","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;63(3):479\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1338_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","volume":"55","author":"LR Solomon","year":"2010","unstructured":"Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis. 2010;55(6):1060\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1338_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.kint.2018.01.018","volume":"93","author":"L Labriola","year":"2018","unstructured":"Labriola L, Jadoul M. Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered. Kidney Int. 2018;93(4):1015\u20136.","journal-title":"Kidney Int"},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1099\/jmm.0.006387-0","volume":"58","author":"Y Qu","year":"2009","unstructured":"Qu Y, Istivan TS, Daley AJ, Rouch DA, Deighton MA. Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms. J Med Microbiol. 2009;58(Pt 4:442\u201350.","journal-title":"J Med Microbiol"},{"issue":"2","key":"1338_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.clnu.2013.04.014","volume":"33","author":"S Oncu","year":"2014","unstructured":"Oncu S. Optimal dosage and dwell time of ethanol lock therapy on catheters infected with Candida species. Clin Nutr. 2014;33(2):360\u20132.","journal-title":"Clin Nutr"},{"key":"1338_CR17","series-title":"Presented at the ICAAC Congress","first-page":"952","volume-title":"Effectiveness of ethanol-based lock solutions on catheter biofilm microorganisms","author":"O Lesens","year":"2013","unstructured":"Lesens O, Balestrino D, Charbonnel N, Aumeran C, Traore O, Forestier C, Souweine B. Effectiveness of ethanol-based lock solutions on catheter biofilm microorganisms, Presented at the ICAAC Congress; 2013. p. 952."},{"issue":"10","key":"1338_CR18","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/ndt\/gfp187","volume":"24","author":"D Balestrino","year":"2009","unstructured":"Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traore O, Forestier C. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant. 2009;24(10):3204\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1338_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/502607","volume":"26","author":"CJ Crnich","year":"2005","unstructured":"Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005;26(8):708\u201314.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"0","key":"1338_CR20","first-page":"0","volume":"0","author":"DL Landry","year":"2015","unstructured":"Landry DL, Jaber RA, Hanumanthappa N, Lipkowitz GS, O'Shea MH, Bermudez H, Hathorne AP, Braden GL. Effects of prolonged ethanol lock exposure to carbothane- and silicone-based hemodialysis catheters: a 26-week study. J Vasc Access. 2015;0(0):0.","journal-title":"J Vasc Access"},{"issue":"2","key":"1338_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/rcm.2837","volume":"21","author":"S Guenu","year":"2007","unstructured":"Guenu S, Heng AE, Charbonne F, Galmier MJ, Charles F, Deteix P, Souweine B, Lartigue C. Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60% ethanol solution. Rapid Commun Mass Spectrom. 2007;21(2):229\u201336.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1338_CR22","volume-title":"Submission","author":"D Balestrino","year":"2015","unstructured":"Balestrino D, Quintana M, Charbonnel N, Forestier C, Souweine B, Lartigue C. Ethanol 40% \/ enoxaparin 400 UI\/mL lock solution: in vitro antibiofilm activity and compatibility with polyurethane catheter. In: Submission; 2015."},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2369-13-146","volume":"13","author":"JK Broom","year":"2012","unstructured":"Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of heparin versus EthAnol lock THerapY for the prevention of catheter associated infecTion in hemodialysis patients--the HEALTHY-CATH trial. BMC Nephrol. 2012;13:146.","journal-title":"BMC Nephrol"},{"issue":"9","key":"1338_CR24","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11255-018-1855-4","volume":"50","author":"T Zhao","year":"2018","unstructured":"Zhao T, Liu H, Han J. Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(9):1643.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"1338_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.5414\/CN106559","volume":"75","author":"AE Heng","year":"2011","unstructured":"Heng AE, Abdelkader MH, Diaconita M, Nony A, Guerraoui A, Caillot N, Rince M, Deteix P, Souweine B. Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol. 2011;75(6):534\u201341.","journal-title":"Clin Nephrol"},{"issue":"6","key":"1338_CR26","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/ndt\/gfq205","volume":"25","author":"R Vanholder","year":"2010","unstructured":"Vanholder R, Canaud B, Fluck R, Jadoul M, Labriola L, Marti-Monros A, Tordoir J, Van Biesen W. Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant. 2010;25(6):1753\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"1338_CR27","unstructured":"Recommandations de la soci\u00e9t\u00e9 fran\u00e7aise d\u2019hygi\u00e8ne hospitali\u00e8re. Bonnes pratiques d'hygi\u00e8ne en h\u00e9modialyse. Revue officielle de la soci\u00e9t\u00e9 fran\u00e7aise d'hygi\u00e8ne hospitali\u00e8re. 2005;13(2):136-9."},{"issue":"1","key":"1338_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"key":"1338_CR29","unstructured":"Rapport annuel du r\u00e9seau de surveillance des infections en h\u00e9modialyse (DIALIN) 2013. \n                    http:\/\/www.cpias-auvergnerhonealpes.fr\/Reseaux\/DIALIN\/Resultats\/Rapport_annuel_2013.pdf\n                    \n                  ."},{"key":"1338_CR30","unstructured":"Agence de la biom\u00e9decine. Rapport annuel du R\u00e9seau Epid\u00e9miologie et Information en N\u00e9phrologie (REIN) 2012. \n                    https:\/\/www.agence-biomedecine.fr\/IMG\/pdf\/rapport_rein_vdef_2012.pdf\n                    \n                  ."},{"issue":"10","key":"1338_CR31","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1093\/ndt\/gfu253","volume":"29","author":"M Noordzij","year":"2014","unstructured":"Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, Stojceva-Taneva O, Leivestad T, Buturovic-Ponikvar J, Benitez Sanchez M, et al. Use of vascular access for hemodialysis in Europe: a report from the ERA-EDTA registry. Nephrol Dial Transplant. 2014;29(10):1956\u201364.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1338_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000274461","volume":"29","author":"M Venditto","year":"2010","unstructured":"Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, Bessette C, Deray G, Mercadal L. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin\/gentamicin. Blood Purif. 2010;29(3):268\u201373.","journal-title":"Blood Purif"},{"issue":"1","key":"1338_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1523-1755.2005.00414.x","volume":"68","author":"A Ishani","year":"2005","unstructured":"Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS wave 2 study. Kidney Int. 2005;68(1):311\u20138.","journal-title":"Kidney Int"},{"issue":"4","key":"1338_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/sdi.12115","volume":"26","author":"SD Kosa","year":"2013","unstructured":"Kosa SD, Lok CE. The economics of hemodialysis catheter-related infection prophylaxis. Semin Dial. 2013;26(4):482\u201393.","journal-title":"Semin Dial"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1338-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:43:36Z","timestamp":1589881416000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1338-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1338-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol, the information and consent forms, and the investigator\u2019s brochure on Ethenox have received authorization from the \u201ccpp-sudest6\u201d (AU 1269) ethics committee and the Agence National de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM) (2016-A00180-51). The investigator explain the study to the patient and give him\/her the information form. The patients willing to participate in the study sign a written consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"149"}}